Analyst Ratings for Aastrom Biosciences (ASTM)
ASTM Rating Summary
ASTM Price Target Summary
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$5.18 (+824.1%)
Avg. $ Target:
$5.18 (+824.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/20/2012 | Roth Capital | Downgrade | Neutral (Buy) |
2.30 (7.00) |
1.82 | 0.56 | -69.23% | Details |
| 7/24/2012 | WBB Securities | Upgrade | Strong Buy (Buy) |
N/A (N/A) |
1.96 | 0.56 | -71.43% | Details |
| 5/22/2012 | Needham & Company | New Coverage | Buy (N/A) |
5.00 (N/A) |
2.16 | 0.56 | -74.07% | Details |
| 5/16/2012 | Ascendiant Capital | New Coverage | Strong Buy (N/A) |
4.25 (N/A) |
2.32 | 0.56 | -75.86% | Details |
| 10/21/2011 | Oppenheimer | New Coverage | Perform (N/A) |
N/A (N/A) |
2.31 | 0.56 | -75.76% | Details |
| 9/22/2011 | JMP Securities | New Coverage | Market Outperform (N/A) |
6.00 (N/A) |
2.39 | 0.56 | -76.57% | Details |
| 8/12/2011 | Global Hunter Securities | New Coverage | Buy (N/A) |
6.00 (N/A) |
2.23 | 0.56 | -74.89% | Details |
| 3/28/2011 | Stifel Nicolaus | New Coverage | Buy (N/A) |
N/A (N/A) |
2.21 | 0.56 | -74.66% | Details |
| 8/16/2010 | National Securities | New Coverage | Buy (N/A) |
N/A (N/A) |
1.53 | 0.56 | -63.4% | Details |
